Jury Awards USD 8 Million to Illumina in Patent Fight with BGI
shot by IP News Shots / 6:38 pm on 03 December, 2021
A federal jury at the U.S. District Court for the Northern District of California ruled in favour of Illumina, Inc. in DNA patent infringement fight with BGI Genomics (currently known as BGI Group). The jury found Illumina’s four out of five patent valid and also awarded USD 8 million.
Industry: Biotechnology | Type of IP: Litigations
Read more at Law360